WALL, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced Herkimer County, NY (Herkimer) has selected BIO-key�s PortalGuard IAM platform to provide its workforce with secure access to mission-critical data to meet their cybersecurity insurance requirements.

Herkimer County sought a flexible and agile IAM platform to add Multi-Factor Authentication (MFA) to their security stack to support cybersecurity compliance requirements without disrupting their users� workflows. Solution flexibility was essential to the Herkimer project because their user groups� experience levels varied, so they needed a solution that provided enhanced security and optimal ease of use. PortalGuard enables the County's IT team to leverage the platform�s seventeen available authentication methods to allow Administrators and users to choose the method that best fits their workflow and access scenarios at that moment. No headaches, no interruptions - PortalGuard just works while simplifying IT touchpoints. PortalGuard delivers user-friendly, scalable access security that keeps organizations ahead of ever-changing security threats and meets their enterprise compliance goals.

"We are proud to add Herkimer County to our growing community of county government customers," said Mark Cochran, President of BIO-key - PortalGuard. "Especially in the COVID era, getting ahead of emerging threats is a top priority for county governments. We hear from our customers that to be successful in this endeavor, they need to thwart the sophistication of today's cyberattacks with robust access security controls to verify users while also improving the user experience. By leveraging the PortalGuard IAM platform designed for the modern workforce, county governments can secure access to their critical data cost-effectively and meet their compliance requirements without negatively impacting their users."

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key:
Facebook � Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn � Corporate: https://www.linkedin.com/company/bio-key-international
Twitter � Corporate: @BIOkeyIntl
Twitter � Investors: @BIO_keyIR
StockTwits: BIO_keyIR

BIO-key Media Contact:
Erin Knapp
Matter Communications
[email protected]
914-260-3158

Investor Contacts:
William Jones, David Collins
Catalyst IR
[email protected]
212-924-9800